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Invariant natural killer T (iNKT) cells recognize lipid antigens presented by
and non-invariant NKT cells (1) . NKT cells demonstrate autoreactivity towards endogenous lipid antigens, show enrichment in tissues such as the liver and adipose tissue, and exhibit potent effector functions in immunity (2, 3) . Since iNKT cells represent long-lived tissue resident cells in most organs (4) , tight regulation of iNKT cell homeostasis is required to prevent inappropriate inflammation. Studies of intestinal iNKT cells suggest that this tissue residency may be established during narrow time frames of early life through microbially regulated homing and expansion that results in a finely tuned steady-state level of local iNKT cells (5, 6) . Further, as iNKT cells exhibit limited proliferation and carefully coordinated tissue trafficking under non-inflammatory conditions (4, 5, (7) (8) (9) , it is likely that strict control of iNKT cell levels and their activation is important to maintain tissue homeostasis.
Consistent with this, triggering iNKT cell activation in the context of their numeric increase in germ-free mice leads to profound inflammation of the colon which is prevented by blockade of CD1d (5, 6 ).
These peripheral, extrathymic mechanisms of control of iNKT cells are poorly understood but likely include the levels of cytokines and hormones, for example, which can directly regulate iNKT cell responses as well as alter the threshold to iNKT cell activation by endogenous lipid autoantigens (10-12). This further suggests that the activation of iNKT cells, and potentially their homeostasis, may be regulated by the balance between activating and non-activating lipids, and thus by lipid presentation by CD1d (13, 14) . However, iNKT cells exhibit similar proliferation and survival after transfer into wild-type (WT) and CD1d-deficient mice, which has suggested that CD1d expression in the periphery is dispensable for the regulation of iNKT cell homeostasis (7, 8) . Whether tissue-and cell-type specific effects of CD1d-dependent regulation of iNKT cell homeostasis exist remains to be addressed, however.
Here we demonstrate, using mouse models with hepatocyte-specific deletion of CD1d and microsomal triglyceride transfer protein (MTP), an intracellular lipid transfer protein responsible for CD1d lipidation and biogenesis (15) (16) (17) (18) (19) , that hepatocytes control liver iNKT cell homeostasis through MTP-and CD1d-dependent transcriptional regulation of iNKT cell apoptosis. Furthermore, we show that these regulatory mechanisms are critical for the prevention of uncontrolled hepatic inflammation upon iNKT cell activation.
RESULTS

Hepatocyte-specific deletion of Mttp is associated with structural and functional alterations in CD1d
To delete Mttp, the gene encoding MTP, in a hepatocyte-specific manner, Alb-Cre mice transcript uses an alternative exon 1B that would escape targeting in the conditional knockout mice described above (16, 23) . However, quantitative PCR (qPCR) with exon-specific primers revealed that Mttp transcripts in hepatocytes almost exclusively contained exon 1A (Fig. 1A) . Accordingly, primary hepatocytes from Alb-Cre;Mttp fl/fl mice (hereafter, hepatocyte (H)-Mttp -/-mice) exhibited a dramatic decrease in Mttp transcripts containing exon 1A without a compensatory increase in the expression of transcripts containing exon 1B (Fig.   1B ). This is consistent with strongly reduced hepatocyte MTP protein expression in these mice (14) .
MTP can directly transfer phospholipids onto CD1d (16, 17) . Accordingly, Mttp mutations in patients with abetalipoproteinemia (ABL) are associated with severe defects in lipid antigen presentation by group 1 (CD1a, CD1b, CD1c) and group 2 (CD1d) CD1 (18) . In dendritic cells of ABL patients, group 1 CD1 undergoes proteasomal degradation, while CD1d shows unimpaired expression but is unable to load exogenous antigens (18) . Consistent with these findings, hepatocytes of H-Mttp -/-mice demonstrated unimpaired cell surface and intracellular expression of CD1d as measured by the 1B1 monoclonal antibody (Fig. 1C) . However, analysis of CD1d expression using an extended panel of monoclonal and polyclonal antibodies showed that a subset of antibodies exhibited impaired recognition of CD1d at the cell-surface of H-Mttp -/-hepatocytes ( Fig. 1D ). This subset of antibodies included the monoclonal antibodies 19G11, 15C6, and 20H2, which potently blocked CD1d-restricted antigen presentation by hepatocytes ( Fig. 1E ) and were previously demonstrated to bind to adjacent clusters of epitopes in the vicinity of the CD1d antigen binding groove (24).
Quantitative PCR showed a minor increase in Cd1d1 expression by H-Mttp -/-hepatocytes indicating that impaired CD1d recognition by a subset of monoclonal anti-CD1d antibodies was not the consequence of decreased CD1d expression (Fig. 1F) . Together, these results
show that deletion of hepatocyte Mttp and associated defects in lipid transfer onto CD1d lead to impaired recognition of CD1d by a subset of monoclonal antibodies, thus suggesting structural alterations in CD1d in the absence of this lipid transfer protein.
To address whether deletion of Mttp affects CD1d antigen binding and presentation, we studied the presentation of α-galactosylceramide (α-GalCer), an iNKT cell-activating glycosphingolipid, by wildtype and Mttp-deficient hepatocytes. Alpha-GalCer presentation by
Mttp-deficient hepatocytes was associated with reduced iNKT cell activation, which could not be compensated by loading with higher concentrations of α-GalCer (Fig. 1G, left) . Indeed, iNKT cell-dependent IL-2 release reached a plateau at considerably lower concentrations of α-GalCer upon presentation by H-Mttp -/-compared to WT hepatocytes (Fig. 1G, left) .
Impaired α-GalCer presentation by H-Mttp -/-hepatocytes was not the consequence of altered CD1d trafficking as similar observations were made upon surface loading of α-GalCer onto fixed hepatocytes (Fig. 1G, right) . In addition, defects in antigen presentation were specific to
CD1d since H-2K b -restricted presentation of SIINFEKL did not differ between H-Mttp -/-and WT hepatocytes (Fig. 1H) 
Hepatocyte MTP controls liver iNKT cell homeostasis through regulation of apoptosis
We next investigated whether hepatocyte-specific deletion of Mttp and associated defects in 
Control of liver iNKT cell homeostasis is mediated by hepatocyte CD1d
MTP not only facilitates the loading of lipids onto CD1d but also transfers triglycerides and phospholipids onto apolipoprotein B thus contributing to the secretion of chylomicrons and very low density lipoproteins (VLDL) . Consequently, H-Mttp -/-mice showed an increase in hepatic triglyceride, cholesterol and phospholipid levels ( To further extend these findings, we generated mice with hepatocyte-specific deletion of Cd1d1 (hereafter, H-Cd1d1 -/-mice) by crossing Alb-Cre mice with Cd1d1 fl/fl mice (28).
Cd1d1
fl/fl mice were generated and maintained on the C57BL/6J background, which harbors an inactivating frameshift mutation in Cd1d2 (31). H-Cd1d1 -/-mice, similar to H-Mttp -/-mice, showed an increase in the abundance of iNKT cells but not conventional T cells among liver mononuclear cells (Fig. 4A ). Consistent with results in H-Mttp -/-mice, these alterations in iNKT cell abundance in H-Cd1d1 -/-mice were specific to the liver and not observed in the spleen (Fig. 4B) . Moreover, hepatic iNKT cells but not conventional T cells obtained from H-
-/-mice exhibited a reduction in the percentage of annexin V + cells (Fig. 4C) . These results show that hepatocyte-specific deletion of CD1d is associated with alterations in iNKT Together, our findings reveal a novel pathway of local, tissue-specific control of immunity in the liver, which has important implications for autoimmune and metabolic disorders as well as their associated inflammatory and malignant complications.
MATERIALS AND METHODS
Mice
Experiments were performed with the approval of authorities at the Christian-AlbrechtsUniversity Kiel, the Technical University Dresden, and Harvard Medical School. Mice were housed in a specific pathogen-free (SPF) barrier facility.
, and H-Mttp -/-;4Get mice were described before (14, 22, 41 
Extraction of primary hepatocytes
Primary mouse hepatocytes were isolated as described before (14) .
Flow cytometry
Flow cytometry was performed as previously described (14) . For further information, please refer to SI.
Antigen presentation and ELISAs
Antigen presentation assays were described before (14) . For further information, please refer to SI.
RNA extraction and quantitative PCR
Real-time PCR was performed as described before (14) . For further information, please refer to SI.
Hepatic triglycerides
Hepatic trigylceride levels were determined as described before (22).
Statistical analysis
Datasets of skewed distribution were analyzed using the Mann-Whitney U test and those of Gaussian distribution using the two-tailed Student's t test or, in case of multiple testing, one- Tnf  Tnfrsf10b  Tnfrsf11b  Tnfrsf1a  Cd40  Tnfsf10  Tnfsf12  Cd40lg  Cd70  Traf1  Traf2  Traf3  Trp53  Trp53bp2  Trp53inp1  Trp63  Trp73 
